
Bridge innovation to implementation with high-quality RNA therapeutic raw materials
This article is sponsored by Promega. In today’s fast-paced RNA therapeutic development landscape, experience matters. With over 40 years of experience in RNA synthesis by in vitro transcription (IVT), Promega smooths the transition from research to production by reducing risk and saving time, without compromising the quality of RNA synthesis… Read More















